Home Cart Sign in  
Chemical Structure| 2240-25-7 Chemical Structure| 2240-25-7
Chemical Structure| 2240-25-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Maximum binding velocity for bovine Xanthine oxidase

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of 4-Amino-5-bromopyrimidin-2(1H)-one

CAS No. :2240-25-7
Formula : C4H4BrN3O
M.W : 190.00
SMILES Code : O=C1N=C(N)C(Br)=CN1
MDL No. :MFCD00056025
InChI Key :QFVKLKDEXOWFSL-UHFFFAOYSA-N
Pubchem ID :75233

Safety of 4-Amino-5-bromopyrimidin-2(1H)-one

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302-H315-H317-H318-H335
Precautionary Statements:P261-P280-P305+P351+P338

Application In Synthesis of 4-Amino-5-bromopyrimidin-2(1H)-one

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2240-25-7 ]

[ 2240-25-7 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 71-30-7 ]
  • [ 2240-25-7 ]
YieldReaction ConditionsOperation in experiment
95.6% With N-Bromosuccinimide In N,N-dimethyl-formamide at 15℃; for 1 h; Sonication The cytosine (55.6g, 0.5mol), N-bromosuccinimide (106.8g, 0 . 6mol) and DMF150mL in added in the reaction bottle, cooling to 15 °C ultrasonic reaction 1h, TLC raw material the reaction is complete, filtering, the filter cake is washed with water (20 ml × 2) washing, drying to obtain 5-bromocytosine (90.9g, 95.6percent).
References: [1] Patent: CN103819412, 2016, B, . Location in patent: Paragraph 0023-0025; 0031-0032; 0037; 0038.
[2] Synthesis, 2005, # 7, p. 1103 - 1108.
[3] Tetrahedron Letters, 1992, vol. 33, # 50, p. 7779 - 7782.
[4] ACS Medicinal Chemistry Letters, 2019, vol. 10, # 2, p. 180 - 185.
[5] Chemistry Letters, 1987, p. 2311 - 2312.
[6] Chemistry - A European Journal, 2019, .
[7] Bulletin of the Chemical Society of Japan, 1989, vol. 62, # 11, p. 3750 - 3751.
[8] Journal of Organic Chemistry, 1982, vol. 47, # 6, p. 1018 - 1023.
  • 2
  • [ 148214-56-6 ]
  • [ 2240-25-7 ]
References: [1] Journal of the American Chemical Society, 1934, vol. 56, p. 134,138.
  • 3
  • [ 71-30-7 ]
  • [ 51-20-7 ]
  • [ 2240-25-7 ]
References: [1] Journal of Labelled Compounds and Radiopharmaceuticals, 1994, vol. 34, # 7, p. 603 - 616.
  • 4
  • [ 71-30-7 ]
  • [ 2240-25-7 ]
References: [1] Journal of the American Chemical Society, 1934, vol. 56, p. 134,138.
 

Historical Records

Categories